CD28 and Autoimmunity: Given its functional importance in the initiation of T cell expansion and differentiation, CD28 has been an attractive target for therapeutic intervention [4], and blockers of the CD28 pathway are now approved for use in autoimmunity (abatacept) and transplantation (belatacept).